Table 2. Tumor response in all patients.
Best response | IBP group | Non-IBP group | P value |
---|---|---|---|
CR, n (%) | 0 (0) | 0 (0) | |
PR, n (%) | 6 (15.4) | 10 (11.6) | |
SD, n (%) | 29 (74.3) | 43 (50.0) | |
PD, n (%) | 4 (10.3) | 33 (38.4) | |
ORR, n (%) | 6 (15.4) | 10 (11.6) | 0.560 |
DCR, n (%) | 35 (89.7) | 53 (61.6) | 0.001 |
CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; IBP, immunotherapy beyond progression.